申请人:Ashton Mark
公开号:US20070015799A1
公开(公告)日:2007-01-18
This invention relates to compounds of formula (I) which are glyoxalase I inhibitors, pharmaceutical salts or compositions comprising such compounds, and the use of such compositions and compounds to treat various conditions alleviated by the inhibition of glyoxalase 1. Wherein X is N or CH. R
2
is H, CF
3
; or optionally substituted C
5-6
aryl, C
3-7
cycloalkyl, C
5-7
heterocyclyl. R
3
is H; or optionally substituted C
5-6
aryl, C
3-7
cycloalkyl, C
5-7
heterocyclyl. Alternatively R
2
and R
3
together form an optionally substituted C
3-4
alkylene group wherein L
3
and L
4
are single bonds thus forming a C
5-6
ring fused with the aromatic ring to which L
3
and L
4
are attached. L
3
and L
4
are independently selected from a single bond, optionally substituted C
1-4
alkylene, -L
9
YN(OH)C(═O)L
10
- and -L
9
C(═O)N(OH)YL
10
-, wherein L
9
and L
10
are independently selected from optionally substituted C
1-4
alkylene, C
5-6
arylene, C
1-4
alkylene-C
5-6
arylene and a single bond, wherein Y is NH or a single bond.
本发明涉及式(I)的化合物,它们是乙二醛酶I抑制剂,包括此类化合物的药物盐或组合物,以及使用这种组合物和化合物来治疗通过抑制乙二醛酶1缓解的各种疾病。其中X是N或CH。R2为H、CF3;或者是可选取代的C5-6芳基、C3-7环烷基、C5-7杂环基。R3为H;或者是可选取代的C5-6芳基、C3-7环烷基、C5-7杂环基。或者R2和R3一起形成一个可选取代的C3-4烷基,其中L3和L4是单键,从而形成一个与L3和L4连接的芳环。L3和L4分别独立选择自单键、可选取代的C1-4烷基、-L9YN(OH)C(═O)L10-和-L9C(═O)N(OH)YL10-,其中L9和L10分别独立选择自可选取代的C1-4烷基、C5-6芳基、C1-4烷基-C5-6芳基和单键,其中Y为NH或单键。